BILL & MELINDA GATES FOUNDATION

Bill Gates Portfolio

BILL & MELINDA GATES FOUNDATION is an investment fund managing more than 126.5M US dollars ran by Bill Gates. The largest holdings include Vir Biotechnology, Immunocore Holdings and BioNTech SE. In Q3 2022 the fund bought assets of total value of 14.6M US dollars and sold assets of total value of 300K US dollars.

$126.5M

portfolio value

-14.23%

quarter

-69.95%

1 year

BILL & MELINDA GATES FOUNDATION portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q3 2021	54800000	293900000
Q1 2022	9300000	74100000
Q3 2022	14600000	300000

BILL & MELINDA GATES FOUNDATION 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology Vir Biotechnology, Inc. Portfolio share: 23.79% Portfolio value: 30.1M Avg. open price: $40.62 Current price: $26.57 P/L: -34.59% Bought +130.04% shares Q1 2022	share	23.79%	30.1M	$40.62	$26.57	-34.59%	Bought +130.04% shares Q1 2022
Biotechnology Immunocore Holdings plc Portfolio share: 21.42% Portfolio value: 27.1M Avg. open price: N/A Current price: $58.07 P/L: N/A N/A Q1 2021	share	21.42%	27.1M	N/A	$58.07	N/A	N/A Q1 2021
Biotechnology BioNTech SE Portfolio share: 15.89% Portfolio value: 20.1M Avg. open price: N/A Current price: $166.71 P/L: N/A Sold -85.69% shares Q3 2021	share	15.89%	20.1M	N/A	$166.71	N/A	Sold -85.69% shares Q3 2021
Diagnostics & Research LumiraDx Limited Portfolio share: 11.54% Portfolio value: 14.6M Avg. open price: N/A Current price: $1.23 P/L: N/A N/A Q3 2022	share	11.54%	14.6M	N/A	$1.23	N/A	N/A Q3 2022
Biotechnology CureVac N.V. Portfolio share: 10.67% Portfolio value: 13.5M Avg. open price: N/A Current price: $7.6 P/L: N/A Sold -45.46% shares Q1 2022	share	10.67%	13.5M	N/A	$7.6	N/A	Sold -45.46% shares Q1 2022
Biotechnology Exscientia plc Portfolio share: 10.36% Portfolio value: 13.1M Avg. open price: N/A Current price: $5.51 P/L: N/A N/A Q4 2021	share	10.36%	13.1M	N/A	$5.51	N/A	N/A Q4 2021
Medical Devices Butterfly Network, Inc. Portfolio share: 3.79% Portfolio value: 4.8M Avg. open price: N/A Current price: $3.26 P/L: N/A N/A Q1 2021	share	3.79%	4.8M	N/A	$3.26	N/A	N/A Q1 2021
Biotechnology Atreca, Inc. Portfolio share: 1.66% Portfolio value: 2.1M Avg. open price: N/A Current price: $1 P/L: N/A Sold -0.79% shares Q3 2022	share	1.66%	2.1M	N/A	$1	N/A	Sold -0.79% shares Q3 2022
Specialty Chemicals Amyris, Inc. Portfolio share: 0.71% Portfolio value: 900K Avg. open price: N/A Current price: $1.83 P/L: N/A N/A Q4 2020	share	0.71%	900K	N/A	$1.83	N/A	N/A Q4 2020
Specialty Chemicals Zymergen Inc. Portfolio share: 0.16% Portfolio value: 200K Avg. open price: N/A Current price: $2.43 P/L: N/A N/A Q2 2021	share	0.16%	200K	N/A	$2.43	N/A	N/A Q2 2021

Showing TOP 10 BILL & MELINDA GATES FOUNDATION's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of BILL & MELINDA GATES FOUNDATION?

The biggest position of the BILL & MELINDA GATES FOUNDATION is Vir Biotechnology, Inc. (VIR) with 23.79% portfolio share worth of 30.1M US dollars.

Top 5 BILL & MELINDA GATES FOUNDATION's holdings represent 83.32% of the portfolio:

Vir Biotechnology, Inc. (VIR) – 23.79%
Immunocore Holdings plc (IMCR) – 21.42%
BioNTech SE (BNTX) – 15.89%
LumiraDx Limited (LMDX) – 11.54%
CureVac N.V. (CVAC) – 10.67%

Who is the portfolio manager of BILL & MELINDA GATES FOUNDATION?

The portfolio manager of the BILL & MELINDA GATES FOUNDATION is Bill Gates.

What is the total asset value of the BILL & MELINDA GATES FOUNDATION portfolio?

BILL & MELINDA GATES FOUNDATION total asset value (portfolio value) is 126.5M US dollars.

Who is Bill Gates?

Bill Gates is the portfolio manager of the BILL & MELINDA GATES FOUNDATION.

What is Bill Gates (BILL & MELINDA GATES FOUNDATION) fund performance?

BILL & MELINDA GATES FOUNDATION's quarterly performance is -14.23%, annualy -69.95%.

What is the BILL & MELINDA GATES FOUNDATION CIK?

BILL & MELINDA GATES FOUNDATION's Central Index Key is 0001663801 .